Toshinobu Yamamoto
Shonan Institute of Technology(JP)Japan Medical Association(JP)Mitsubishi Tanabe Pharma Corporation
Publications by Year
Research Areas
Barrier Structure and Function Studies, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Connexins and lens biology
Most-Cited Works
- → Identification of Toxin A-Negative, Toxin B-Positive Clostridium difficile by PCR(1998)362 cited
- → Regulation of the blood?biliary barrier: interaction between gap and tight junctions in hepatocytes(2003)127 cited
- → Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk(2016)83 cited
- → Transforming growth factor‐β induces epithelial to mesenchymal transition by down‐regulation of claudin‐1 expression and the fence function in adult rat hepatocytes(2007)81 cited
- → Analysis of Clostridium difficile Isolates from Nosocomial Outbreaks at Three Hospitals in Diverse Areas of Japan(2001)75 cited
- → IL-1β regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways